block 9 board review part 3 endocrine 7march2014 chauncey d. tarrant, m.d. chief of residents 13-14

87
Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

Upload: theodore-giles-malone

Post on 24-Dec-2015

217 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

Block 9 Board ReviewPart 3

Endocrine7March2014

Chauncey D. Tarrant, M.D.Chief of Residents 13-14

Page 2: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

Why are we STILL reviewing ENDOCRINE???

Page 3: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

3.5% of Initial Certifying Exam!!!

Page 4: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

Pediatrics In Review Articles

• Type 2 Diabetes Mellitus• Cushing’s Disease• Grave’s Disease• Puberty/Delayed Puberty

Page 5: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

PIR Quizzes

Page 6: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

Among the following factors, which is most likely to protect a 13-year-old patient against type 2 diabetes mellitus (DM)?

A. Adolescent age.B. Female sex.C. History of being breastfed.D. Mother who had gestational diabetes.E. Native American race

Page 7: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

Among the following factors, which is most likely to protect a 13-year-old patient against type 2 diabetes mellitus (DM)?

A. Adolescent age.B. Female sex.C. History of being breastfed.D. Mother who had gestational diabetes.E. Native American race

Page 8: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

It can be difficult to distinguish between type 1 and type 2 DM in a child who presents with ketoacidosis.

Among the following, which clinical finding is most suggestive of type 2 DM?

A. Acanthosis nigricans.B. Polydipsia.C. Polyphagia.D. Polyuria.E. Weight loss

Page 9: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

It can be difficult to distinguish between type 1 and type 2 DM in a child who presents with ketoacidosis.

Among the following, which clinical finding is most suggestive of type 2 DM?

A. Acanthosis nigricans.B. Polydipsia.C. Polyphagia.D. Polyuria.E. Weight loss

Page 10: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

In your management of a 7-year-old boy with type 1 DM, which of the following parameters are you likely to assess every 3 months?

A. Albuminuria.B. Hemoglobin A1c.C. Lipid profile.D. Liver function tests.E. Signs of sleep apnea

Page 11: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

In your management of a 7-year-old boy with type 1 DM, which of the following parameters are you likely to assess every 3 months?

A. Albuminuria.B. Hemoglobin A1c.C. Lipid profile.D. Liver function tests.E. Signs of sleep apnea

Page 12: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

In addition to diet and exercise, you are considering pharmacotherapy for a 15-year-old girl who has had type 2 DM for the past year. Among the following, which is the only drug approved by the US Food and Drug Administration for someone her age?

A. Acarbose.B. Exenatide.C. Glipizide.D. Metformin.E. Pioglitazone.

Page 13: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

In addition to diet and exercise, you are considering pharmacotherapy for a 15-year-old girl who has had type 2 DM for the past year. Among the following, which is the only drug approved by the US Food and Drug Administration for someone her age?

A. Acarbose.B. Exenatide.C. Glipizide.D. Metformin.E. Pioglitazone.

Page 14: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

In a patient with newly diagnosed type 2 DM, initiation of insulin therapy is recommended if which one of the following findings is present?

A. Fasting blood glucose level of 140 mg/dL (7.8 mmol/L).

B. Hemoglobin A1c level of 8.0% (0.08).C. Hemoglobin A1c level of 8.5% (0.09).D. Random blood glucose level of 200 mg/dL (11.1

mmol/L).E. Random blood glucose 275 mg/dL (15.3 mmol/L).

Page 15: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

In a patient with newly diagnosed type 2 DM, initiation of insulin therapy is recommended if which one of the following findings is present?

A. Fasting blood glucose level of 140 mg/dL (7.8 mmol/L).

B. Hemoglobin A1c level of 8.0% (0.08).C. Hemoglobin A1c level of 8.5% (0.09).D. Random blood glucose level of 200 mg/dL (11.1

mmol/L).E. Random blood glucose 275 mg/dL (15.3 mmol/L).

Page 16: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

1. Which of the following statements about normal puberty in children is true?A. Bone age correlates better with pubertal development than chronologic age.B. Gonadotropin-releasing hormone (GnRH) secretion in response to negative feedback from sex steroids isconstant throughout life.C. Growth hormone secretion is the sole determinant of the pubertal growth spurt.D. Menarche is the first stage of puberty in girls.E. Normal pubertal development is unrelated to nutritional status.

Page 17: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

1. Which of the following statements about normal puberty in children is true?A. Bone age correlates better with pubertal development than chronologic age.B. Gonadotropin-releasing hormone (GnRH) secretion in response to negative feedback from sex steroids isconstant throughout life.C. Growth hormone secretion is the sole determinant of the pubertal growth spurt.D. Menarche is the first stage of puberty in girls.E. Normal pubertal development is unrelated to nutritional status.

Page 18: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

2. Which of the following statements best describes adrenarche?A. Breast development becomes evident in girls.B. Hypothalamic production of adrenocorticotropin hormone increases.C. Maternal estrogens are withdrawn, causing neonatal acne.D. Spermatozoa begin to appear in seminal fluid.E. The adrenal gland increases production of dehydroepiandrosterone sulfate.

Page 19: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

2. Which of the following statements best describes adrenarche?A. Breast development becomes evident in girls.B. Hypothalamic production of adrenocorticotropin hormone increases.C. Maternal estrogens are withdrawn, causing neonatal acne.D. Spermatozoa begin to appear in seminal fluid.E. The adrenal gland increases production of dehydroepiandrosterone sulfate.

Page 20: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

3. Which of the following is the primary action of luteinizing hormone?A. Secretion of follicle-stimulating hormone.B. Secretion of GnRH from the pituitary gland.C. Stimulation of gametogenesis in the testes.D. Stimulation of the gonads to produce androgens.E. Stimulation of the ovarian follicle to produce estrogen

Page 21: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

3. Which of the following is the primary action of luteinizing hormone?A. Secretion of follicle-stimulating hormone.B. Secretion of GnRH from the pituitary gland.C. Stimulation of gametogenesis in the testes.D. Stimulation of the gonads to produce androgens.E. Stimulation of the ovarian follicle to produce estrogen

Page 22: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

4. At which of the following phases of the menstrual cycle is the concentration of progesterone the highest?A. The beginning of the follicular phase.B. The beginning of the luteal phase.C. The end of the luteal phase.D. The middle of the follicular phase.E. The middle of the luteal phase.

Page 23: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

4. At which of the following phases of the menstrual cycle is the concentration of progesterone the highest?A. The beginning of the follicular phase.B. The beginning of the luteal phase.C. The end of the luteal phase.D. The middle of the follicular phase.E. The middle of the luteal phase.

Page 24: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

6. Normal pubertal development varies according to a child’s weight and ethnicity. Which of the followingclinical findings indicates premature pubertal development?A. Penile enlargement in a 10-year-old African American male of normal weight.B. Stage 3 pubic hair in a 7-year-old Mexican American girl of normal weight.C. Testicular enlargement in a 9-year-old white boy who is obese.D. Thelarche in a 7-year-old African American girl of normal weight.E. Thelarche in a 9-year-old white girl who is obese.

Page 25: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

Normal pubertal development varies according to a child’s weight and ethnicity. Which of the followingclinical findings indicates premature pubertal development?A. Penile enlargement in a 10-year-old African American male of normal weight.B. Stage 3 pubic hair in a 7-year-old Mexican American girl of normal weightC. Testicular enlargement in a 9-year-old white boy who is obese.D. Thelarche in a 7-year-old African American girl of normal weight.E. Thelarche in a 9-year-old white girl who is obese.

Page 26: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

7. You are seeing a 13-year-old girl who experienced menarche 3 months ago. Her physical examination shows that the areolae form a secondary mound above the contour of her breasts. Her pubic hair is curly and coarse and covers the lower portion of her mons pubis. Which of the following is the most accurate description of her Sexual Maturity Rating?A. Breast: stage 2, pubic hair: stage 3.B. Breast: stage 3, pubic hair: stage 3.C. Breast: stage 3, pubic hair: stage 4.D. Breast: stage 4, pubic hair: stage 4.E. Breast: stage 4, pubic hair: stage 5.

Page 27: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

You are seeing a 13-year-old girl who experienced menarche 3 months ago. Her physical examination shows that the areolae form a secondary mound above the contour of her breasts. Her pubic hair is curly and coarse and covers the lower portion of her mons pubis. Which of the following is the most accurate description of her Sexual Maturity Rating?A. Breast: stage 2, pubic hair: stage 3.B. Breast: stage 3, pubic hair: stage 3.C. Breast: stage 3, pubic hair: stage 4.D. Breast: stage 4, pubic hair: stage 4.E. Breast: stage 4, pubic hair: stage 5.

Page 28: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

8. Which of the following is a true statement regarding normal pubertal development?A. Behavioral changes in adolescence are a direct manifestation of increases in sex hormoneconcentrations.B. Bone age is an accurate determinant of height potential in boys and girls.C. Most girls miss periods for 90 days within 1 year of menarche.D. Pubertal gynecomastia is rare and should prompt an investigation.E. The pubertal growth spurt in girls typically occurs within 2 to 3 months after menarche.

Page 29: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

8. Which of the following is a true statement regarding normal pubertal development?A. Behavioral changes in adolescence are a direct manifestation of increases in sex hormone concentrations.B. Bone age is an accurate determinant of height potential in boys and girls.C. Most girls miss periods for 90 days within 1 year of menarche.D. Pubertal gynecomastia is rare and should prompt an investigation.E. The pubertal growth spurt in girls typically occurs within 2 to 3 months after menarche.

Page 30: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

9. Which of the following patients should undergo an evaluation to rule out organic pathology as a cause for abnormal pubertal development at this time?A. A 6-year-old white girl who has unilateral thelarche, normal growth velocity, and no pubic hair development.B. A 7-year-old Mexican American boy who has breast development and testicular enlargement.C. A 13-year-old African American girl who has a recent growth spurt and no menarche.D. A 13-year-old white boy who has no testicular enlargement and normal growth velocity.E. A 16-year-old African American girl who has excessive pubic hair and normal menstrual cycles.

Page 31: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

9. Which of the following patients should undergo an evaluation to rule out organic pathology as a cause for abnormal pubertal development at this time?A. A 6-year-old white girl who has unilateral thelarche, normal growth velocity, and no pubic hair development.B. A 7-year-old Mexican American boy who has breast development and testicular enlargement.C. A 13-year-old African American girl who has a recent growth spurt and no menarche.D. A 13-year-old white boy who has no testicular enlargement and normal growth velocity.E. A 16-year-old African American girl who has excessive pubic hair and normal menstrual cycles.

Page 32: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

Match the clinical scenario with the most likely diagnosis.6. 13–11/12-year-old girl who has secondary amenorrhea and a body mass index of 13 kg/m2.7. 14–10/12-year-old girl who has primary amenorrhea and is a competitive gymnast.8. 15–1/12-year-old tall boy who has small testes and Sexual Maturity Rating 5 pubic hair.9. 16–9/12-year-old short girl who has primary amenorrhea and a webbed neck.10. 17–5/12-year-old boy who has small testes and anosmia.A. Constitutional delayed puberty.B. Functional gonadotropin deficiency.C. Kallman syndrome.D. Klinefelter syndrome.E. Turner syndrome.

Page 33: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

Match the clinical scenario with the most likely diagnosis.13–11/12-year-old girl who has secondary amenorrhea and a body mass index of 13 kg/m2. B14–10/12-year-old girl who has primary amenorrhea and is a competitive gymnast. B15–1/12-year-old tall boy who has small testes and Sexual Maturity Rating 5 pubic hair. D16–9/12-year-old short girl who has primary amenorrhea and a webbed neck. E10. 17–5/12-year-old boy who has small testes and anosmia. CA. Constitutional delayed puberty.B. Functional gonadotropin deficiency.C. Kallman syndrome.D. Klinefelter syndrome.E. Turner syndrome.

Page 34: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

CONTENT SPECS!!!

Page 35: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

Type 2 Diabetes Mellitus

Page 36: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

How can you tell the difference between Type 1 and Type 2 DM?

Page 37: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What the difference between Type 1 and Type 2 DM?

Sometimes the difference is hard to distinguishType 1: Autoimmune destruction of B cells,

thus no insulinType 2: Increased insulin resistance with

relative insulin deficiency

Page 38: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What is Acanthosis Nigricans a marker for?

Page 39: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What is Acanthosis Nigricans a marker for?

• Insulin Resistance

Page 40: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What are the treatment approaches to Type 2 DM?

Page 41: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What are the treatment approaches to Type 2 DM?

• Diabetes “team”• Diet and Exercise modification• Insulin in for random glc on >250• Metformin in >10yrs

Page 42: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What screening tests should you do for a patient with Type 2 DM?

Page 43: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What screening tests should you do for a patient with Type 2 DM?

• Hbgb A1C q3mo• BP qvisit• LFTs at diagnosis and annually• Eye exam at diagnosis and annually• Lipid panel at diagnosis and annually• UA at diagnosis and annually• Assess for symptoms of sleep apnea at

diagnosis and annually

Page 44: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What are long term complications of Type 2 DM?

Page 45: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What are long term complications of Type 2 DM?

• Microvascular (retinopathy, neuropathy, nephropathy)

• Macrovascualr (HTN, hyperlipidemia)

– May be present at diagnosis

Page 46: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

Cushing’s Syndrome

Page 47: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What are the signs and symptoms of Cushing Syndrome?

Page 48: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What are the signs and symptoms of Cushing Syndrome?

• Obesity• Delayed or absent linear growth

– May or may not be present• Acne• Virilization• Hirsuitism• Round Facies• HTN• Lethargy/Depression• Osteoporosis• Myopathy• Striae• Buffalo hump

Page 49: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What is the most common cause of Cushing Syndrome?

Page 50: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What is the most common cause of Cushing Syndrome?

• Protracted use of Exogenous Corticosteroids (including topical, oral, and inhaled)

Page 51: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What is the lab evaluation for a patient with suspected Cushing Syndrome?

Page 52: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What is the lab eval for a patient with suspected Cushing Syndrome?

• 24hr urine free cortisol• Midnight Plasma and Salivary Cortisol• Low dose Dexamethasone suppression• 1mg Dexamethasone suppression

Page 53: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

Hyperthyroidism

Page 54: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What are the signs and symptoms of Grave’s Disease?

Page 55: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What are the signs and symptoms of Grave’s Disease?

• tachycardia • weight loss• increased appetite• heat intolerance• Tremor• Exophthalmos• eyelid lag• moist skin• fine hair • Restlessness• emotional lability• short attention span• declining school performance• fatigue

Page 56: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What are the signs and symptoms of Neonatal Hyperthyroidism?

Page 57: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What are the signs and symptoms of Neonatal Hyperthyroidism?

• Irritability• Tremor• Flushing • Hyperactivity• Increased bowel motility• Thrombocytopenia• Cardiac dysfunction• hepatosplenomegaly

Page 58: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What are the treatment options for hyperthyroidism?

Page 59: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What are the treatment options for hyperthyroidism?

• Antithyroid medications• Radioiodine Ablation• Surgery

Page 60: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

Puberty

Page 61: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

Distinguish between Normal and Abnormal Gynecomastia in males

Page 62: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

Distinguish between Normal and Abnormal Gynecomastia in males

• Normal– Occurs after the onset of genital development in

50%– Usually last less than 1 year

• Abnormal– Any variation from this– Prior to puberty is ABNORMAL

Page 63: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What is the significance of a breast mass in an adolescent girl?

Page 64: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What is the significance of a breast mass in an adolescent girl?

• Likely benign

Page 65: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What is the differential diagnosis for precocious puberty?

Page 66: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What is the differential diagnosis for precocious puberty?

• CNS tumors• Ovarian tumors• Ovarian Cysts• Feminizing Adrenal tumors• McCune Albright• CAH• Leydig Cell tumors• Familial Male Precocious Puberty

Page 67: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What is premature thelarche?

Page 68: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What is premature thelarche?

• Early breast development without other signs of puberty in girls

• Common in ages 1-4yrs• Regresses spontaneously

• Breast development before puberty (without other signs of puberty) in boys is ABNORMAL! RULE OUT NEOPLASM!

Page 69: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What tumors may produce precocious puberty?

Page 70: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What tumors may produce precocious puberty?

• Liver• CNS• Ovary• Testes• Adrenal Glands

Page 71: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What are the causes of precocious puberty?

Page 72: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What are the causes of precocious puberty?

• early activation of the HPG axis, with gonadotropins stimulating sex hormone production

• More common in girls than boys• Idiopathic• CNS disorders (more common in boys)• Overweight/obesity• Gonadotropin Independent (adrenal/gonad disorders)

or exogenous hormones• McCune Albright Syndrome (non classic CAH)• Neoplasms (rare)

Page 73: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What are the signs and symptoms of delayed puberty?

Page 74: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What are the signs and symptoms of delayed puberty?

• Delayed puberty is defined as lack of breast development by age 13.0 years in girls and lack of pubertal testicular development (genital stage 2) by age 14.0 years in boys

• Slowing of linear growth

Page 75: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What are the causes of delayed puberty?

Page 76: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What are causes of delayed puberty?

Page 77: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What is the natural history of constitutional delayed puberty?

Page 78: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What is the natural history of constitutional delayed puberty?

• Once puberty begins, its course and tempo are normal, and catch-up growth to target height occurs– No puberty by age 18 in boys= PATHOLOGIC

Page 79: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

When is treatment for constitutional delayed puberty indicated?

Page 80: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

When is treatment for constitutional delayed puberty indicated?

• If a negative self image is present

Page 81: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What are the therapeutic options for delayed puberty??

Page 82: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

What are the therapeutic options for delayed puberty??

• Testosterone– IM– Oral– Transdermal• Gels• Patch

• Estrogen– Oral– Transdermal

Page 83: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14

Quick Associations

Page 84: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14
Page 85: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14
Page 86: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14
Page 87: Block 9 Board Review Part 3 Endocrine 7March2014 Chauncey D. Tarrant, M.D. Chief of Residents 13-14